These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 22666468

  • 1. Low immune response to hepatitis B vaccine among children in Dakar, Senegal.
    Rey-Cuille MA, Seck A, Njouom R, Chartier L, Sow HD, Mamadou, Ka AS, Njankouo M, Rousset D, Giles-Vernick T, Unal G, Sire JM, Garin B, Simon F, Vray M.
    PLoS One; 2012; 7(5):e38153. PubMed ID: 22666468
    [Abstract] [Full Text] [Related]

  • 2. HBV immunization and vaccine coverage among hospitalized children in Cameroon, Central African Republic and Senegal: a cross-sectional study.
    Bekondi C, Zanchi R, Seck A, Garin B, Giles-Vernick T, Gody JC, Bata P, Pondy A, Tetang SM, Ba M, Ekobo CS, Rousset D, Sire JM, Maylin S, Chartier L, Njouom R, Vray M.
    BMC Infect Dis; 2015 Jul 12; 15():267. PubMed ID: 26164361
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis B virus exposure during childhood in Cameroon, Central African Republic and Senegal after the integration of HBV vaccine in the expanded program on immunization.
    Rey-Cuille MA, Njouom R, Bekondi C, Seck A, Gody C, Bata P, Garin B, Maylin S, Chartier L, Simon F, Vray M.
    Pediatr Infect Dis J; 2013 Oct 12; 32(10):1110-5. PubMed ID: 23694839
    [Abstract] [Full Text] [Related]

  • 4. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA, Assudani D, Kuriyakose S, Van Der Meeren O.
    Hum Vaccin Immunother; 2014 Oct 12; 10(10):2795-8. PubMed ID: 25483640
    [Abstract] [Full Text] [Related]

  • 5. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
    Avdicova M, Crasta PD, Hardt K, Kovac M.
    Vaccine; 2015 May 28; 33(23):2727-33. PubMed ID: 24962750
    [Abstract] [Full Text] [Related]

  • 6. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).
    Bar-On ES, Goldberg E, Fraser A, Vidal L, Hellmann S, Leibovici L.
    Cochrane Database Syst Rev; 2009 Jul 08; (3):CD005530. PubMed ID: 19588375
    [Abstract] [Full Text] [Related]

  • 7. A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth.
    Gatchalian S, Reyes M, Bernal N, Lefevre I, David MP, Han HH, Bock HL, Wolter J, Schuerman L.
    Hum Vaccin; 2005 Jul 08; 1(5):198-203. PubMed ID: 17012860
    [Abstract] [Full Text] [Related]

  • 8. Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic.
    Marshall H, McIntyre P, Roberton D, Dinan L, Hardt K.
    Int J Infect Dis; 2010 Jan 08; 14(1):e41-9. PubMed ID: 19467896
    [Abstract] [Full Text] [Related]

  • 9. Primary vaccination of infants against hepatitis B can be completed using a combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis-Haemophilus influenzae type B vaccine.
    Lim FS, Han HH, Jacquet JM, Bock HL.
    Ann Acad Med Singap; 2007 Oct 08; 36(10):801-6. PubMed ID: 17987229
    [Abstract] [Full Text] [Related]

  • 10. Integration of hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B virus, inactivated poliomyelitis and Haemophilus influenzae type b conjugate vaccine within existing national recommendations following a birth dose of monovalent hepatitis B virus vaccine: results of a systematic review in the Asia Pacific region.
    Dolhain J, Janssens W, Sohn WY, Dindore V, Mukherjee P.
    Expert Rev Vaccines; 2019 Sep 08; 18(9):921-933. PubMed ID: 31328999
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine and administered as a single injection, with the DTPa-IPV/Hib and hepatitis B vaccines administered in two simultaneous injections to infants at 2, 4 and 6 months of age.
    Arístegui J, Dal-Ré R, Díez-Delgado J, Marés J, Casanovas JM, García-Corbeira P, De Frutos E, Van Esso D, Verdaguer J, De la Flor J, Moraga F, Boceta R, García-Martínez JA.
    Vaccine; 2003 Sep 08; 21(25-26):3593-600. PubMed ID: 12922087
    [Abstract] [Full Text] [Related]

  • 12. Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth.
    Posuwan N, Wanlapakorn N, Vongpunsawad S, Sintusek P, Leuridan E, Van Damme P, Poovorawan Y.
    Vaccine; 2020 Feb 11; 38(7):1643-1651. PubMed ID: 31948817
    [Abstract] [Full Text] [Related]

  • 13. Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).
    Dhillon S.
    BioDrugs; 2010 Oct 01; 24(5):299-302. PubMed ID: 20795752
    [Abstract] [Full Text] [Related]

  • 14. Hepatitis B infection awareness, vaccine perceptions and uptake, and serological profile of a group of health care workers in Yaoundé, Cameroon.
    Tatsilong HO, Noubiap JJ, Nansseu JR, Aminde LN, Bigna JJ, Ndze VN, Moyou RS.
    BMC Public Health; 2016 Aug 03; 15():706. PubMed ID: 27487845
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis B virus surface antigen and antibody markers in children at a major paediatric hospital after the pentavalent DTP-HBV-Hib vaccination.
    Apiung T, Ndanu TA, Mingle JA, Sagoe KW.
    Ghana Med J; 2017 Mar 03; 51(1):13-19. PubMed ID: 28959067
    [Abstract] [Full Text] [Related]

  • 16. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II, Sami SM, Salama SI, Foud WA, Abdel Hamid AT, Said ZN.
    Egypt J Immunol; 2014 Mar 03; 21(1):13-26. PubMed ID: 25204041
    [Abstract] [Full Text] [Related]

  • 17. Immunization of preterm infants with GSK's hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: A review of safety and immunogenicity.
    Omeñaca F, Vázquez L, Garcia-Corbeira P, Mesaros N, Hanssens L, Dolhain J, Gómez IP, Liese J, Knuf M.
    Vaccine; 2018 Feb 08; 36(7):986-996. PubMed ID: 29336924
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.